resveratrol has been researched along with morphine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argüelles, CF; Granados-Soto, V; Ortiz, MI | 1 |
| Briyal, S; Gupta, YK; Sharma, M | 1 |
| Chien, CC; Chou, KY; Huang, YN; Lin, YS; Shen, CH; Tao, PL; Tsai, RY; Tsai, WY; Wong, CS | 1 |
| Guo, Q; He, X; Huang, C; Ou, P; Wang, Y; Wu, K; Yu, Z | 1 |
| Han, Y; Jamangulova, N; Jiang, C; Liu, W; Song, X; Tang, J; Wang, C; Wu, P; Wu, X; Zhang, G | 1 |
| Cherng, CH; Chou, KY; Tsai, RY; Wang, JC; Wong, CS | 1 |
6 other study(ies) available for resveratrol and morphine
| Article | Year |
|---|---|
The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels.
Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; ATP-Binding Cassette Transporters; Charybdotoxin; Female; Glipizide; Glyburide; KATP Channels; Morphine; Narcotics; Peripheral Nervous System; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tetraethylammonium; Tolbutamide | 2002 |
Antinociceptive effect of trans-resveratrol in rats: Involvement of an opioidergic mechanism.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; India; Injections, Intraperitoneal; Male; Morphine; Naloxone; Pain Measurement; Phytoalexins; Plant Extracts; Rats; Rats, Wistar; Receptors, Opioid; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Time Factors | 2004 |
Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Down-Regulation; Gene Expression Regulation; Inflammation; Male; Morphine; Pain Measurement; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Resveratrol; Stilbenes | 2012 |
Resveratrol attenuates morphine antinociceptive tolerance via SIRT1 regulation in the rat spinal cord.
Topics: Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Tolerance; Histones; Injections, Spinal; Male; Morphine; Narcotics; Nociception; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2014 |
Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cell Line; Drug Tolerance; Interleukin-1beta; Interleukin-6; Mice; Microglia; Morphine; NF-kappa B; Nitric Oxide Synthase Type II; Nociceptive Pain; p38 Mitogen-Activated Protein Kinases; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Resveratrol reverses morphine-induced neuroinflammation in morphine-tolerant rats by reversal HDAC1 expression.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Drug Tolerance; Histone Deacetylase 1; Injections, Spinal; Male; Morphine; Neuralgia; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Resveratrol; Spinal Cord; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |